🇺🇸 FDA
Drug

pralsetinib

Brand: GAVRETO

approved

Quick answer

pralsetinib (GAVRETO), is a pharmaceutical active ingredient, associated with RIGEL PHARMACEUTICALS INC, with approved status in the US.

Key facts

INN
pralsetinib
Brand
GAVRETO
Route
ORAL
Formulation
CAPSULE
Originator
RIGEL PHARMACEUTICALS INC

Frequently asked questions

What is pralsetinib?

pralsetinib (GAVRETO), is a pharmaceutical active ingredient, associated with RIGEL PHARMACEUTICALS INC, with approved status in the US.

What is the brand name for pralsetinib?

GAVRETO is a marketed brand name for pralsetinib. Check FDA Drugs@FDA for the current US label holder.